
BridgeBio Pharma BBIO
$ 70.6
-0.61%
Annual report 2025
added 02-24-2026
BridgeBio Pharma Long Term Debt Current 2011-2026 | BBIO
Annual Long Term Debt Current BridgeBio Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.19 M | 4.51 M | 4.13 M | 3.68 M | 4.94 M | 3.8 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.19 M | 3.68 M | 4.54 M |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
5.82 M | $ 3.54 | -0.7 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
1.03 M | $ 3.25 | 3.83 % | $ 229 M | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M | ||
|
ADC Therapeutics SA
ADCT
|
1.1 M | $ 4.16 | -1.42 % | $ 105 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.8 | 1.81 % | $ 4.36 M | ||
|
argenx SE
ARGX
|
6.53 M | $ 712.23 | 1.27 % | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
14.2 M | $ 228.93 | -0.91 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.39 | -6.09 % | $ 8.16 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
843 K | $ 6.15 | 1.57 % | $ 501 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
4.21 M | $ 6.62 | -0.15 % | $ 181 M | ||
|
BioCardia
BCDA
|
333 K | $ 1.35 | 6.29 % | $ 28.6 M | ||
|
Athersys
ATHX
|
1.01 M | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 3.58 | -0.28 % | $ 7.79 B | ||
|
Catalyst Biosciences
CBIO
|
636 K | $ 11.29 | -2.51 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
1.6 M | $ 14.58 | 1.53 % | $ 214 M | ||
|
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
11 K | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
137 K | $ 2.69 | 1.7 % | $ 16.9 M | ||
|
Curis
CRIS
|
1.34 M | $ 0.89 | 3.74 % | $ 5.61 M | ||
|
BioNTech SE
BNTX
|
45 M | $ 93.04 | 2.76 % | $ 27.2 B | ||
|
Autolus Therapeutics plc
AUTL
|
5.05 M | $ 1.51 | -0.33 % | $ 385 M | ||
|
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M |